Results 1 to 10 of about 19,701 (225)

DPP4 in diabetes [PDF]

open access: yesFrontiers in Immunology, 2015
Dipeptidyl peptidase 4 (DPP4) is a glycoprotein of 110 kDa, which is ubiquitously expressed on the surface of a variety of cells. This exopeptidase selectively cleaves N-terminal dipeptides from a variety of substrates, including cytokines, growth ...
Jürgen Eckel
exaly   +6 more sources

A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2 [PDF]

open access: yesMolecules, 2020
Proteases catalyse irreversible posttranslational modifications that often alter a biological function of the substrate. The protease dipeptidyl peptidase 4 (DPP4) is a pharmacological target in type 2 diabetes therapy primarily because it inactivates ...
Joel Mackay   +2 more
exaly   +12 more sources

DPP4 as a Potential Candidate in Cardiovascular Disease

open access: yesJournal of Inflammation Research, 2022
Si-Yu Chen,1,* Xiang-Quan Kong,1,2,* Ke-Fan Zhang,3,* Shuai Luo,1 Feng Wang,1 Jun-Jie Zhang1,2 1Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, People’s Republic of China; 2Department of Cardiology ...
Jun-Jie Zhang
exaly   +5 more sources

CD26/DPP4 - a potential biomarker and target for cancer therapy [PDF]

open access: yesPharmacology & Therapeutics, 2019
CD26/dipeptidyl peptidase (DPP)4 is a membrane-bound protein found in many cell types of the body, and a soluble form is present in body fluids. There is longstanding evidence that various primary tumors and also metastases express CD26/DPP4 to a variable extent. By cleaving dipeptides from peptides with a proline or alanine in the penultimate position
Gwendolyn Vliegen   +2 more
exaly   +5 more sources

Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease

open access: yesMolecular Metabolism, 2017
Objective: Increased hepatic expression of dipeptidyl peptidase 4 (DPP4) is associated with non-alcoholic fatty liver disease (NAFLD). Whether this is causative for the development of NAFLD is not yet clarified.
Norbert Stefan   +2 more
exaly   +4 more sources

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence [PDF]

open access: yesFrontiers in Pharmacology, 2021
CD26/Dipeptidyl peptidase 4 (DPP4) is a type II transmembrane glycoprotein that is widely expressed in various organs and cells. It can also exist in body fluids in a soluble form. DPP4 participates in various physiological and pathological processes by regulating energy metabolism, inflammation, and immune function.
Hong Fan, Dongguang Wang
exaly   +4 more sources

DPP4 Activity, Hyperinsulinemia, and Atherosclerosis

open access: yesJournal of Clinical Endocrinology and Metabolism, 2021
Abstract Context Obesity and type 2 diabetes are associated with chronic hyperinsulinemia, elevated plasma levels of dipeptidyl peptidase-4 (DPP4), and a pro-atherosclerotic milieu. Evidence Acquisition PubMed search of the term ...
Zhenqi Liu, Kaitlin Love
exaly   +4 more sources

Significance of circulatory DPP4 activity in metabolic diseases [PDF]

open access: yesIUBMB Life, 2018
AbstractDipeptidyl peptidase 4 (DPP4), also known as CD26 is a type II transmembrane protein that is released from the cell membrane in a nonclassical secretory mechanism. This exopeptidase selectively degrades varieties of substrates including incretin hormones, growth factors, and cytokines.
Partha Chakrabarti, Titli Nargis
exaly   +3 more sources

Identification and validation of DPP4 in predicting the prognosis of clear cell RCC [PDF]

open access: yesDiscover Oncology
Dipeptidyl peptidase-4 (DPP4) has been implicated in tumor progression, yet its role in clear cell renal cell carcinoma (KIRC) remains poorly understood. This study aimed to comprehensively investigate the expression profile, prognostic significance, and
Min Luo, Peifeng Li
doaj   +2 more sources

KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes

open access: yesMolecular Metabolism, 2017
Objective: Increasing plasma levels and activity of dipeptidyl peptidase-4 (DPP4 or CD26) are associated with rapid progression of metabolic syndrome to overt type 2 diabetes mellitus (T2DM).
Krishna Kumar   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy